Larimar Therapeutics, Inc. (LRMR)

NASDAQ: LRMR · IEX Real-Time Price · USD

7.71

-0.53 (-6.43%)

At close: Jul 2, 2024, 4:00 PM

8.09

+0.38 (4.93%)

After-hours: Jul 2, 2024, 7:26 PM EDT

Larimar Therapeutics Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2011
Net Income	-36.95	-35.36	-50.64	-42.48	-23.13	Upgrade
Depreciation & Amortization	0.23	0.27	0.34	0.16	0.08	Upgrade
Share-Based Compensation	7.62	6.62	5.47	2.16	0.13	Upgrade
Other Operating Activities	-4.35	0.9	2.72	-2.03	0.23	Upgrade
Operating Cash Flow	-33.46	-27.57	-42.11	-42.2	-22.7	Upgrade
Capital Expenditures	-0.16	-0.1	-0.33	-0.06	-0.08	Upgrade
Acquisitions	0	0	0	41.93	0	Upgrade
Change in Investments	33.52	-90.86	24.5	-23.49	0	Upgrade
Other Investing Activities	-	-	-	-1.3	-	Upgrade
Investing Cash Flow	33.35	-90.96	24.17	17.09	-0.08	Upgrade
Share Issuance / Repurchase	0.03	75.26	19.89	75.59	0	Upgrade
Other Financing Activities	-	-	-	18	19.4	Upgrade
Financing Cash Flow	0.03	75.26	19.89	93.59	19.4	Upgrade
Net Cash Flow	-0.08	-43.27	1.95	68.48	-3.39	Upgrade
Free Cash Flow	-33.62	-27.67	-42.44	-42.26	-22.78	Upgrade
Free Cash Flow Per Share	-0.77	-1.07	-2.47	-3.56	-3.74	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).